CS logo
small CS logo
NSC Research

Johns Creek, Georgia, United States
Cardiologist in Forsyth County, Georgia
5400 Laurel Springs Pkwy STE 1401, Johns Creek, GA 30024

About NSC Research


"Exceptional Cardiac Care In North Atlanta - Dr. Singh is a recognized expert on heart health and preventative care here in the Atlanta area. If you are experiencing heart disease, heart failure, high blood pressure, racing heart, inflammation, fainting, heart flutters or any other cardiovascular symptom contact our expert teams in Cumming, GA and Johns Creek, CA to help manage and solve your issues. Comprehensive Heart Testing In Atlanta, GA - We offer state of the art testing resources to diagnose any heart disease or condition no matter how complex. Our range of services and depth of experience is unrivaled in the Atlanta area."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at NSC Research


During the past decade, NSC Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at NSC Research


According to Clinical.Site data, the most researched conditions in "NSC Research" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Coronary Heart Disease (CHD)" (1 trials), "Heart Failure" (1 trials), "Hyperkalemia" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "NSC Research" in a lesser frequency.

Clinical Trials Intervention Types at NSC Research


Most popular intervention types in "NSC Research" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Tirzepatide" (2 trials), "Dulaglutide" (1 trials), "Evolocumab" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.

Clinical Trials Genders at NSC Research


The vast majority of trials in "NSC Research" are 6 trials for "All" genders.

Clinical Trials Status at NSC Research


Currently, there are NaN active trials in "NSC Research". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NSC Research, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NSC Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".